z-logo
Premium
Advanced Glycation End Products Activate the mi RNA /RhoA/ ROCK 2 Pathway in Endothelial Cells
Author(s) -
Wu Xiaodan,
Liu Weilin,
Zeng Kai,
Lei Hongyi,
Zhang Qingguo,
Zhou Shuqin,
Xu Shiyuan
Publication year - 2014
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/micc.12104
Subject(s) - rhoa , rock2 , apoptosis , microrna , downregulation and upregulation , endothelial stem cell , real time polymerase chain reaction , rho associated protein kinase , microbiology and biotechnology , microarray analysis techniques , cell , rock1 , chemistry , microarray , western blot , gene expression , biology , signal transduction , gene , biochemistry , in vitro
Objective AGE s induce endothelial cell dysfunction in HUVEC s, resulting in ROS production and triggering apoptosis. This study sought to identify mi RNA s involved in AGE ‐induced endothelial cell injury. Methods Microarray analysis to identify mi RNA s altered with AGE stimulation was undertaken, and results were confirmed using real‐time quantitative polymerase chain reaction . The interaction of mi RNA s with the RhoA and ROCK 2 genes was confirmed using luciferase assays, and their effects on expression were determined using Western blot analysis. The effects of AGE s and mi RNA s on endothelial cell permeability were assessed. Results AGE s induced ROS production and apoptosis of HUVEC s ( p  <   0.05). AGE ‐induced miR‐200b and miR‐200c downregulation led to increased expression of their target genes, RhoA and ROCK , respectively. AGE ‐induced endothelial cell permeability and F‐actin expression were significantly reduced with both miR‐200b and miR‐200c mimics ( p  <   0.05). Furthermore, AGE ‐induced stress fiber formation was reduced in cells treated with miR‐200b mimics. Conclusion miR‐200b and miR‐200c are suppressed in AGE ‐induced endothelial cell injury, resulting in unregulated RhoA/ ROCK 2 signaling. Further studies are necessary to evaluate the therapeutic value of targeting mi RNA s or their target genes for treatment of vascular diseases.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom